MedTrace Logo

Continuation of Aspirin Before Isolated Heart Valve Surgery

NCT05151796 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-12-09

No results posted yet for this study

Summary

Whether or not continuing aspirin up to de day before surgery increases the risk of bleeding and/or prevents thrombo-embolic complications remains debated. The investigators retrospectively investigated the whether continuing aspirine within 5 days of isolated heart valve surgery increased the risk of bleeding.

Conditions

  • Isolated Heart Valve Surgery

Interventions

DRUG

Aspirin

Daily aspirin intake for cardiovascular prevention

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Vincent Bonhomme, MD, PhD · CHU of Liège

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-01
Primary Completion
2017-05-01
Completion
2021-12-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05151796 on ClinicalTrials.gov